Background: Bariatric surgery is the most effective therapy for obesity, but targeted weight reduction is not always achieved. Serum lipocalin-2 (LCN2) is closely associated with obesity, but its impact on weight loss after surgery is unknown. We aimed to access the reliability of LCN2 levels and other parameters as effective predictors of excellent weight loss (≥75% excess weight loss [EWL]) 1 year after bariatric surgery.
Methods: This retrospective study evaluated 450 patients (aged 18-65 years) with obesity at 3 months and 1 year after laparoscopic sleeve gastrectomy (LSG) surgery. Seventy-four patients who underwent LSG surgery and met the inclusion and exclusion criteria were included in this study. Serum LCN2, thyroid function, and metabolic and anthropometric parameters were assessed. Weight reduction was expressed as %EWL and percent total weight loss (%TWL) at 3 months and 1 year post surgery. Multivariable logistic regression analysis and receiver operating characteristic (ROC) curve analysis were used to evaluate predictors of ≥75%EWL.
Results: In our cohort, %EWL and %TWL were both strongly associated with preoperative serum LCN2 levels. The binary logistic regression analysis showed that preoperative LCN2, waist circumference, and glycated hemoglobin were independent predictors of excellent weight loss.
Conclusions: Based on these results, we determined a new P index with better predictive value for excellent weight reduction (≥75%EWL) 1 year after LSG surgery.
N.Li: None. L.Su: None. S.Qu: n/a. X.Cheng: n/a. L.Bu: None. B.Xu: None. J.Zeng: None. S.Lei: None. L.Gu: None. L.Feng: None. B.Zhu: None. Y.Huang: n/a. L.Wang: None.
The Tranditional Medicine Project of Shanghai Municipal Health Commission (grant number 2020JP013) ; Shanghai Natural Science Foundation (grant number 21ZR1449400) ; Shanghai Pujiang Talent Plan (grant number 18PJD038)